OklahomaSB 933Oklahoma 2026 Regular SessionSenateWALLET

Health care; creating the Right to Try for Individualized Treatments Act; authorizing individualized investigational treatments for eligible patients. Effective date.

Sponsored By: Brenda Stanley (Republican)

Signed by Governor

Senate Committee

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

Analyzed Economic Effects

3 provisions identified: 1 benefits, 0 costs, 2 mixed.

Personalized experimental treatments for seriously ill patients

Beginning November 1, 2026, eligible patients can seek individualized investigational treatments. You must have a life‑threatening or severely debilitating illness and have tried approved options. Your doctor must recommend it based on genomic analysis and document that you qualify. You must sign written informed consent that explains risks, possible outcomes, and costs. The treatment must be made and given inside an eligible facility that operates under a Federalwide Assurance, and no manufacturer is required to offer it.

Provider protections and limits on lawsuits

Starting November 1, 2026, licensing boards and Medicare certification bodies cannot act against a provider just for recommending an individualized investigational treatment. State officials cannot block an eligible patient’s access. Giving advice that follows medical standards is allowed. You cannot bring a private lawsuit for harm from these treatments if those involved acted in good faith and used reasonable care.

What patients may pay for these treatments

Starting November 1, 2026, an eligible facility or manufacturer may give an individualized treatment for free or charge you for manufacturing or related costs. The law sets no price caps. Health plans or government agencies may choose to pay, but they do not have to. Hospitals do not have to add new services unless approved. If a patient dies while on the treatment, heirs do not owe debt tied to that treatment.

Sponsors & Cosponsors

Sponsor

Brenda Stanley
Republican • Senate

Cosponsors

Mark Lepak
Republican • House
Marilyn Stark
Republican • House

Roll Call Votes

All Roll Calls

Yes: 99 • No: 3

House vote • 4/29/2026

Top_of_Page

Yes: 82 • No: 2

House vote • 4/15/2026

DO PASS

Yes: 13 • No: 0

House vote • 4/1/2026

DO PASS

Yes: 4 • No: 1

Senate vote • 3/10/2026

THIRD READING

Yes: 0 • No: 0

Senate vote • 3/2/2026